Lysosomal transport disorders.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

17 citing papers in PubMed, 61 citations in OpenAlex.

1. Polymer-based drug delivery systems under investigation for enzyme replacement and other therapies of lysosomal storage disorders.Advanced drug delivery reviews · 2023
   Review
2. Lysosomes as a Target of Anticancer Therapy.International journal of molecular sciences · 2023
   Review
3. Recent Research in Ocular Cystinosis: Drug Delivery Systems, Cysteamine Detection Methods and Future Perspectives.Pharmaceutics · 2020
   Review
4. Pre-clinical Mouse Models of Neurodegenerative Lysosomal Storage Diseases.Frontiers in molecular biosciences · 2020
   Review
5. Lysosomal enzyme replacement therapies: Historical development, clinical outcomes, and future perspectives.Advanced drug delivery reviews · 2017
   Review
6. Functional characterization of the lysosomal membrane protein TMEM192 in mice.Oncotarget · 2017
   Article
7. The development and use of small molecule inhibitors of glycosphingolipid metabolism for lysosomal storage diseases.Journal of lipid research · 2014
   Review
8. Quality control gone wrong: mitochondria, lysosomal storage disorders and neurodegeneration.British journal of pharmacology · 2014
   Review
9. An extended proteome map of the lysosomal membrane reveals novel potential transporters.Molecular & cellular proteomics : MCP · 2013
   Article
10. Mitochondrial Ca2+ homeostasis in lysosomal storage diseases.Cell calcium · 2008
    Review
11. Molecular physiology and pathophysiology of lysosomal membrane transporters.Journal of inherited metabolic disease · 2008
    Review
12. Killing of intraerythrocytic Plasmodium falciparum by lysosomotropic amino acid esters.Parasitology research · 2003
    Article
13. New aspects of the pathogenesis of cystinosis.Pediatric nephrology (Berlin, Germany) · 2003
    Review
14. The H+-coupled electrogenic lysosomal amino acid transporter LYAAT1 localizes to the axon and plasma membrane of hippocampal neurons.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2003
    Article
15. Cystinosin, the protein defective in cystinosis, is a H(+)-driven lysosomal cystine transporter.The EMBO journal · 2001
    Article
16. Identification and characterization of a lysosomal transporter for small neutral amino acids.Proceedings of the National Academy of Sciences of the United States of America · 2001
    Article
17. Autophagy, mitochondria and cell death in lysosomal storage diseases.Autophagy
    Article

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

Authors and funding

3 authors at 2 institutions in 1 country.

Funding

No grant is acknowledged in the PubMed record.

Abstract

Indexed as